Canned Beans Recalled in 23 States Due to Potential 'Life-Threatening' Risk
Yellowstone Brown Sugar Molasses Baked Beans are being recalled in nearly half of the U.S. states due to a potentially harmful undeclared allergen.
The U.S. Food and Drug Administration announced on May 2 that the Vietti Food Group based in Nashville is recalling 4,515 cases of the beans 'due to the presence of undeclared soy,' which is potentially 'life-threatening' to those allergic to the ingredient.
The FDA said in a press release, 'Individuals with an allergy or severe sensitivity to soy risk serious or life-threatening allergic reactions if they consume this product.'
The recalled Yellowstone baked beans are sold in 15-ounce cans and display a best-by date of Feb. 17, 2028, Eating Well reported.
A representative for the food brand told the outlet that the affected beans were sold before the recall at Walmart, Associated Wholesale Grocers, K-VA-T Food Stores, Hy-Vee and Meijer.
Getty Walmart store in Ridgecrest, Calif.
Walmart store in Ridgecrest, Calif.
Related: FDA Recalls Nearly 200,000 Cans of Green Beans for Potential Contamination
The recall is happening in the following states: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, New Hampshire, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah and Virginia.
Soy comes from soybeans and is commonly consumed in foods. It is part of the nine major allergens, which include milk, eggs, fish, shellfish, tree nuts, peanuts, wheat and sesame.
Food Allergy Research and Education states on its website that soy allergy is 'more common in infants and young children,' with approximately 0.4% of infants in the U.S. affected.
According to WebMD, 'Soy can cause some mild stomach and intestinal side effects such as constipation, bloating, and nausea. It can also cause allergic reactions involving rash, itching, and breathing problems in some people.'
The outlet adds that soy is 'possibly unsafe' for children allergic to cow's milk, when used as an alternative to the milk.
Getty Can of baked beans
Can of baked beans
Related: 12 Deaths Reported amid Listeria Outbreak Linked to Recalled Frozen Shakes
Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
The FDA stated there have been no illnesses or adverse reactions to date following the recall, per the release.
'Consumers who have purchased the affected product are urged to return it to the place of purchase for a full refund,' they added.
This latest recall comes after nearly 200,000 cans of Good & Gather Cut Green Beans were recalled by the FDA due to potential contamination with a foreign object in March.
Read the original article on People

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26
Ascendis Pharma A/S (NASDAQ:ASND) is among the 13 Biotech Stocks with Huge Upside Potential. It reported interim Week 26 data from its Phase 2 COACH Trial, confirming that combining TransCon hGH (lonapegsomatropin) with TransCon CNP (navepegritide) raised annualized growth velocity (AGV) and height Z-scores in children with achondroplasia. A close-up view of a hand manipulating a syringe while delivering TransCon CNP into a tumor. A mean AGV of 9.14 cm/year and a +0.53 Z-score rise were attained by treatment-naïve youngsters (N=12). Children (N=9) treated with TransCon CNP in the past achieved an AGV of 8.25 cm/year with a +0.44 Z-score improvement. The majority of side effects were modest, and safety remained consistent with monotherapies. The COACH Trial is the first to assess this combination in kids between the ages of two and eleven. While TransCon CNP is undergoing FDA priority review, TransCon hGH is approved as SKYTROFA® for juvenile growth hormone insufficiency. The treatment focuses on the FGFR3-CNP signaling imbalance that is at the heart of achondroplasia, a disorder that affects more than 250,000 people worldwide. It is anticipated that the results of week 52 and a scheduled Phase 3 trial in Q4 2025 will further clarify efficacy and long-term benefits. The biopharmaceutical business Ascendis Pharma A/S (NASDAQ:ASND) uses its TransCon technology platform to significantly improve patient outcomes. While we acknowledge the potential of ASND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.
Yahoo
34 minutes ago
- Yahoo
Enoki Mushrooms Recalled Nationwide for Potential Listeria Contamination—Here's What to Know
If you've recently grabbed some enoki mushrooms, you'll want to check your fridge. Packages of Enoki mushrooms from Hofood99 Inc. have been recalled by the FDA due to potential contamination with Listeria. The mushrooms that were recalled were sold nationwide and packaged in green plastic. They were in a 200-gram package with a UPC Barcode 6 976532 310051 on the back label, distributed by Hofood99 Inc., 21903 56th Ave., Oakland Gardens, NY 11364. Related: Are Food Recalls Really on the Rise? A Food Microbiologist Weighs In So far, no illnesses have been reported in relation to the mushrooms, but Listeria monocytogenes is a common cause of food safety recalls. Listeria can cause high fevers, severe headache, stiffness, nausea, and diarrhea in healthy people—but infection with listeria can cause stillbirth or miscarriage in pregnant women, and deadly infections in young children, the elderly, and people with weakened immune systems. Related: How to Wash Every Type of Mushroom So They're Safe to Eat If you have the affected products, do not eat them. You can destroy the mushrooms or return them to the store for a full refund. If you have any questions, you can contact Hofood99 at 917-756-9833, between 9 a.m. and 2 p.m., Monday to Friday. Read the original article on Real Simple
Yahoo
34 minutes ago
- Yahoo
Illinois becomes first state to require that all insurance covers Alzheimer's treatment
SPRINGFIELD, Ill. (WCIA) — Illinois is making a major expansion in patient care and access to new treatment for Alzheimer's, thanks to a new state law taking effect in July 2025. Gov. J.B. Pritzker signed a bill that will require state health insurance to cover U.S. Food and Drug Administration (FDA) approved medicine to slow down Alzheimer's and other related diseases. SEE ALSO: New Illinois laws and tax changes set to kick in on July 1, 2025 Some Alzheimer's patients will no longer have to go through step therapy — a process where insurers require patients to try and test less expensive drugs before covering the actual medication prescribed by their doctor. The Alzheimer's Association Illinois Chapter, which has been a forefront advocate for this, called the law 'groundbreaking.' 'For people living with Alzheimer's, slowing the progression of the disease changes someone's life — not only that individual's life, but the lives of their caregivers and all those around them, family and friends,' said David Olson, Director of State Affairs at the Alzheimer's Association Illinois Chapter. This coverage will also include diagnostic testing at the doctor's request. This ensures patients can access an accurate diagnosis before even starting the treatment. In 2020, there were 230,000 seniors with Alzheimer's disease or a related dementia in the state, and according to the Illinois Department of Health, that number is expected to increase to 260,000 this year. With the rise in medical costs, insurance coverage is essential for most families. Bill creating Office of State Public Defender heads to Pritzker's desk The bill's sponsor in the House, Rep. Mary Gill (D-Chicago), said with dementia, time is always at the essence. 'When it comes to slowing Alzheimer's and other dementias, every moment counts,' Gill said. 'We can't waste time on insurance gimmicks like step therapy to save a few bucks, which is why I'm thankful for the strong advocacy and bipartisan support this legislation received.' Other private insurance plans will also begin covering FDA-approved treatment starting in 2027. 'We worked collaboratively with the insurance industry on this legislation,' Olson said. 'We were able to find and agree upon language here that expands access in a way that also isn't increasing cost to consumers.' Currently, there are two types of treatments for Alzheimer's approved by the FDA. One is Lecanemab, and the other is Donanemab. These will not end the disease, as there is currently no cure for Alzheimer's. This law makes Illinois the first state to require such treatment, and advocates said they hope other states will follow its lead. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.